OBJECTIVE: To present nationally representative estimates of the effect of cancer care on out-of-pocket medical expenditures and lost productivity for the working-aged population. STUDY DESIGN: Secondary data analysis. METHODS: Pooled data from the Medical Expenditure Panel Survey were used for the analysis. We constructed the following 4 respondent groups for comparison during the analysis period: (1) respondents with no cancer, and (among those who reported having cancer) (2) respondents with active cancer care, (3) respondents with follow-up Cancer care, and (4) respondents with no cancer care. Using regression analysis, we estimated the effect of being in each of the cancer care groups on out-of-pocket medical expenditures, the probability of being employed, and the annual number of workdays missed because of illness or injury. RESULTS: Being actively treated for cancer increases the mean annual out-of-pocket medical expenditures by $1170 compared with not having cancer. Less intensive cancer care is associated with lower medical expenditures (but still higher than for those without cancer). Respondents undergoing active cancer care were less likely to be employed full-time. Among respondents who were employed, those undergoing active cancer care missed 22.3 more workdays per year than those without cancer. CONCLUSION: Changes to the health system need to consider not only how to reduce inappropriate medical utilization but also how to ensure that those diagnosed as having cancer and other serious medical conditions will not be doubly burdened with poor health and high medical expenditures.
OBJECTIVE: To present nationally representative estimates of the effect of cancer care on out-of-pocket medical expenditures and lost productivity for the working-aged population. STUDY DESIGN: Secondary data analysis. METHODS: Pooled data from the Medical Expenditure Panel Survey were used for the analysis. We constructed the following 4 respondent groups for comparison during the analysis period: (1) respondents with no cancer, and (among those who reported having cancer) (2) respondents with active cancer care, (3) respondents with follow-up Cancer care, and (4) respondents with no cancer care. Using regression analysis, we estimated the effect of being in each of the cancer care groups on out-of-pocket medical expenditures, the probability of being employed, and the annual number of workdays missed because of illness or injury. RESULTS: Being actively treated for cancer increases the mean annual out-of-pocket medical expenditures by $1170 compared with not having cancer. Less intensive cancer care is associated with lower medical expenditures (but still higher than for those without cancer). Respondents undergoing active cancer care were less likely to be employed full-time. Among respondents who were employed, those undergoing active cancer care missed 22.3 more workdays per year than those without cancer. CONCLUSION: Changes to the health system need to consider not only how to reduce inappropriate medical utilization but also how to ensure that those diagnosed as having cancer and other serious medical conditions will not be doubly burdened with poor health and high medical expenditures.
Authors: Gery P Guy; Donatus U Ekwueme; K Robin Yabroff; Emily C Dowling; Chunyu Li; Juan L Rodriguez; Janet S de Moor; Katherine S Virgo Journal: J Clin Oncol Date: 2013-09-16 Impact factor: 44.544
Authors: Jacqueline Casillas; Kevin C Oeffinger; Melissa M Hudson; Mark L Greenberg; Mark W Yeazel; Kirsten K Ness; Tara O Henderson; Leslie L Robison; Gregory T Armstrong; Qi Liu; Wendy Leisenring; Yutaka Yasui; Paul C Nathan Journal: Health Serv Res Date: 2015-01-20 Impact factor: 3.402
Authors: Maria Pisu; Kelly M Kenzik; Robert A Oster; Patricia Drentea; Kimlin T Ashing; Mona Fouad; Michelle Y Martin Journal: Cancer Date: 2015-01-06 Impact factor: 6.860
Authors: Florence K L Tangka; Sujha Subramanian; Madeleine Jones; Patrick Edwards; Timothy Flanigan; Yevgeniya Kaganova; Kevin W Smith; Cheryll C Thomas; Nikki A Hawkins; Juan Rodriguez; Temeika Fairley; Gery P Guy Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-03 Impact factor: 4.254
Authors: Matthew P Banegas; Gery P Guy; Janet S de Moor; Donatus U Ekwueme; Katherine S Virgo; Erin E Kent; Stephanie Nutt; Zhiyuan Zheng; Ruth Rechis; K Robin Yabroff Journal: Health Aff (Millwood) Date: 2016-01 Impact factor: 6.301